On May 16, 2024, the U.S. Department of Justice (DOJ) released a Notice of Proposed Rulemaking initiating a formal rulemaking process to consider reclassifying marijuana from a Schedule I drug (e.g., heroin, LSD) to a Schedule III drug (e.g., ketamine, Tylenol with codeine) under the Controlled Substances Act (CSA).  Unlike Schedule I drugs which have no currently accepted medical use and a high potential for abuse, Schedule III drugs have accepted medical uses with a moderate to low potential for physical or psychological dependence (but do require a valid prescription from a licensed health care provider to be legally obtained and used).

To view this Alert, please log-in to the POOL/PACT HR’s website at www.poolpact.com.  Once you log-in to the website: 

1.      Choose “Human Resources” under the Resource Library tab at the top of the page.

2.      To the right choose “HR Alerts/Notices.”

3.      Then choose “2. Current Alerts” and scroll down to view this Alert entitled, “ALERT: DOJ Issues Notice of Proposed Rulemaking to Reschedule Marijuana.” 

Please contact your HR Business Partner if you have any questions.